Browsing by Keyword : Proto-Oncogene Proteins c-met
Showing results 15 to 22 of 22
Pub Year | | Title | AJOU Author(s) |
2014 | | Met degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression. | 강성운, 김철호, 이복순 |
2014 | | MET expression is associated with disease-specific survival in breast cancer patients in the neoadjuvant setting. | 고영화 |
2015 | | MET is a predictive factor for late recurrence but not for overall survival of early stage hepatocellular carcinoma. | 고영화 |
2024 | | MET overexpression in ovarian cancer via CD24-induced downregulation of miR-181a: A signalling for cellular quiescence-like state and chemoresistance in ovarian CSCs | 권지은 |
2005 | | Presence of autocrine hepatocyte growth factor-Met signaling and its role in proliferation and migration of SNU-484 gastric cancer cell line. | 김욱환, 박민선, 이재호, 조혜성 |
2021 | | Quantitation of ligand is critical for ligand-dependent MET signalling activation and determines MET-targeted therapeutic response in gastric cancer | 김석휘, 이다근, 한재호 |
2016 | | The Dual Inhibition of Met and EGFR by ME22S, a Novel Met/EGFR Bispecific Monoclonal Antibody, Suppresses the Proliferation and Invasion of Laryngeal Cancer | 김철호, 이복순 |
2004 | | Transforming variant of Met receptor confers serum independence and anti-apoptotic property and could be involved in the mouse thymic lymphomagenesis. | 이재호 |
1